440 related articles for article (PubMed ID: 31768599)
1. Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.
Choi H; Kim YK; Yoon EJ; Lee JY; Lee DS;
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):403-412. PubMed ID: 31768599
[TBL] [Abstract][Full Text] [Related]
2. Prediction of post-stroke cognitive impairment using brain FDG PET: deep learning-based approach.
Lee R; Choi H; Park KY; Kim JM; Seok JW
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1254-1262. PubMed ID: 34599654
[TBL] [Abstract][Full Text] [Related]
3. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
[TBL] [Abstract][Full Text] [Related]
4. Deep learning only by normal brain PET identify unheralded brain anomalies.
Choi H; Ha S; Kang H; Lee H; Lee DS;
EBioMedicine; 2019 May; 43():447-453. PubMed ID: 31003928
[TBL] [Abstract][Full Text] [Related]
5. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW;
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905
[TBL] [Abstract][Full Text] [Related]
6. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
Kishore N; Goel N
Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
8. Distinct subtypes of spatial brain metabolism patterns in Alzheimer's disease identified by deep learning-based FDG PET clusters.
Ryoo HG; Choi H; Shi K; Rominger A; Lee DY; Lee DS;
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):443-454. PubMed ID: 37735259
[TBL] [Abstract][Full Text] [Related]
9. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
Choi H; Jin KH;
Behav Brain Res; 2018 May; 344():103-109. PubMed ID: 29454006
[TBL] [Abstract][Full Text] [Related]
10. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
12. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
[TBL] [Abstract][Full Text] [Related]
13.
Peng J; Wang W; Song Q; Hou J; Jin H; Qin X; Yuan Z; Wei Y; Shu Z
Acad Radiol; 2023 Sep; 30(9):1874-1884. PubMed ID: 36587998
[TBL] [Abstract][Full Text] [Related]
14. Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
Ni YC; Tseng FP; Pai MC; Hsiao IT; Lin KJ; Lin ZK; Lin WB; Chiu PY; Hung GU; Chang CC; Chang YT; Chuang KS;
Ann Nucl Med; 2021 Aug; 35(8):889-899. PubMed ID: 34076857
[TBL] [Abstract][Full Text] [Related]
15. Multi-stage classification of Alzheimer's disease from
Thakur M; Snekhalatha U
Phys Eng Sci Med; 2022 Dec; 45(4):1301-1315. PubMed ID: 36357627
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
17. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
18. Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Prats-Climent J; Gandia-Ferrero MT; Torres-Espallardo I; Álvarez-Sanchez L; Martínez-Sanchis B; Cháfer-Pericás C; Gómez-Rico I; Cerdá-Alberich L; Aparici-Robles F; Baquero-Toledo M; Rodríguez-Álvarez MJ; Martí-Bonmatí L
J Med Syst; 2022 Jun; 46(8):52. PubMed ID: 35713815
[TBL] [Abstract][Full Text] [Related]
19. Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
Feng W; Halm-Lutterodt NV; Tang H; Mecum A; Mesregah MK; Ma Y; Li H; Zhang F; Wu Z; Yao E; Guo X
Int J Neural Syst; 2020 Jun; 30(6):2050032. PubMed ID: 32498641
[TBL] [Abstract][Full Text] [Related]
20. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
